Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
ASCO Annual meetingASCO Annual meeting
Not Confirmed
Not Confirmed
30 May-03 June, 2025
ISPE BiotechnologyISPE Biotechnology
Not Confirmed
Not Confirmed
02-03 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
ASCO Annual meetingASCO Annual meeting
Industry Trade Show
Not Confirmed
30 May-03 June, 2025
ISPE BiotechnologyISPE Biotechnology
Industry Trade Show
Not Confirmed
02-03 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
29 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/29/3090200/0/en/Maze-Therapeutics-to-Participate-in-the-Jefferies-2025-Global-Healthcare-Conference.html
14 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/14/3081551/0/en/Maze-Therapeutics-Reports-First-Quarter-2025-Financial-Results-and-Reiterates-Upcoming-Milestones.html
13 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/13/3079990/0/en/Maze-Therapeutics-to-Participate-in-the-3rd-Annual-H-C-Wainwright-BioConnect-Investor-Conference.html
31 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/31/3052174/0/en/Maze-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Recent-Highlights.html
07 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/07/3022751/0/en/Maze-Therapeutics-Doses-First-Patient-in-Phase-2-HORIZON-Clinical-Trial-Evaluating-MZE829-as-a-Potential-Treatment-for-APOL1-Kidney-Disease.html
30 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/31/3018524/0/en/Maze-Therapeutics-Announces-Pricing-of-Upsized-Initial-Public-Offering.html
ABOUT THIS PAGE